Sangro B - Search Results

1

Safety, Efficacy, and Pharmacodynamics of Tremelimumab Plus Durvalumab for Patients With Unresectable Hepatocellular Carcinoma: Randomized Expansion of a Phase I/II Study.

Kelley RK, Sangro B, Harris W, Ikeda M, Okusaka T, Kang YK, Qin S, Tai DW, Lim HY, Yau T, Yong WP, Cheng AL, Gasbarrini A, Damian S, Bruix J, Borad M, Bendell J, Kim TY, Standifer N, He P, Makowsky M, Negro A, Kudo M, Abou-Alfa GK. Kelley RK, et al. Among authors: sangro b. J Clin Oncol. 2021 Sep 20;39(27):2991-3001. doi: 10.1200/JCO.20.03555. Epub 2021 Jul 22. J Clin Oncol. 2021. PMID: 34292792 Free PMC article. Clinical Trial.

2

Hepatitis B and C viral infections in patients with hepatocellular carcinoma.

Ruiz J, Sangro B, Cuende JI, Beloqui O, Riezu-Boj JI, Herrero JI, Prieto J. Ruiz J, et al. Among authors: sangro b. Hepatology. 1992 Sep;16(3):637-41. doi: 10.1002/hep.1840160305. Hepatology. 1992. PMID: 1380480

3

Influence of tumor characteristics on the outcome of liver transplantation among patients with liver cirrhosis and hepatocellular carcinoma.

Herrero JI, Sangro B, Quiroga J, Pardo F, Herraiz M, Cienfuegos JA, Prieto J. Herrero JI, et al. Among authors: sangro b. Liver Transpl. 2001 Jul;7(7):631-6. doi: 10.1053/jlts.2001.25458. Liver Transpl. 2001. PMID: 11460231 Free article.

4

Efficacy and toxicity of intra-arterial cisplatin and etoposide for advanced hepatocellular carcinoma.

Sangro B, Rios R, Bilbao I, Beloqui O, Herrero JI, Quiroga J, Prieto J. Sangro B, et al. Oncology. 2002;62(4):293-8. doi: 10.1159/000065059. Oncology. 2002. PMID: 12138235

5

Phase I trial of intratumoral injection of an adenovirus encoding interleukin-12 for advanced digestive tumors.

Sangro B, Mazzolini G, Ruiz J, Herraiz M, Quiroga J, Herrero I, Benito A, Larrache J, Pueyo J, Subtil JC, Olagüe C, Sola J, Sádaba B, Lacasa C, Melero I, Qian C, Prieto J. Sangro B, et al. J Clin Oncol. 2004 Apr 15;22(8):1389-97. doi: 10.1200/JCO.2004.04.059. J Clin Oncol. 2004. PMID: 15084613 Clinical Trial.

6

Future therapies for hepatocellular carcinoma.

Sangro B, Mazzollini G, Prieto J. Sangro B, et al. Eur J Gastroenterol Hepatol. 2005 May;17(5):515-21. doi: 10.1097/00042737-200505000-00007. Eur J Gastroenterol Hepatol. 2005. PMID: 15827441 Review.

7

Radioembolization using 90Y-resin microspheres for patients with advanced hepatocellular carcinoma.

Sangro B, Bilbao JI, Boan J, Martinez-Cuesta A, Benito A, Rodriguez J, Panizo A, Gil B, Inarrairaegui M, Herrero I, Quiroga J, Prieto J. Sangro B, et al. Int J Radiat Oncol Biol Phys. 2006 Nov 1;66(3):792-800. doi: 10.1016/j.ijrobp.2006.05.065. Epub 2006 Aug 14. Int J Radiat Oncol Biol Phys. 2006. PMID: 16904840

8

Liver transplantation in patients with hepatocellular carcinoma across Milan criteria.

Herrero JI, Sangro B, Pardo F, Quiroga J, Iñarrairaegui M, Rotellar F, Montiel C, Alegre F, Prieto J. Herrero JI, et al. Among authors: sangro b. Liver Transpl. 2008 Mar;14(3):272-8. doi: 10.1002/lt.21368. Liver Transpl. 2008. PMID: 18306328 Free article.

9

[Diagnosis and treatment of hepatocellular carcinoma].

Forner A, Ayuso C, Isabel Real M, Sastre J, Robles R, Sangro B, Varela M, de la Mata M, Buti M, Martí-Bonmatí L, Bru C, Tabernero J, Llovet JM, Bruix J. Forner A, et al. Among authors: sangro b. Med Clin (Barc). 2009 Feb 28;132(7):272-87. doi: 10.1016/j.medcli.2008.11.024. Epub 2009 Feb 14. Med Clin (Barc). 2009. PMID: 19248879 Spanish. No abstract available.

10

Treatment of hepatocellular carcinoma by radioembolization using 90Y microspheres.

Sangro B, Bilbao JI, Iñarrairaegui M, Rodriguez M, Garrastachu P, Martinez-Cuesta A. Sangro B, et al. Dig Dis. 2009;27(2):164-9. doi: 10.1159/000218349. Epub 2009 Jun 22. Dig Dis. 2009. PMID: 19546555 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

357 results

Search Page